Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
26th May 2020
Last week we provided advice on how to prevent your child suffering from digital eyestrain. This week, we're looking at adults, in particular those working from home (most of us at the moment!). Ian...Read more
30th April 2020
If you have an issue with your eye, while we aren’t able to see you in person, we might suggest you send us images for us to take a look at. It is important that the images are the best possible qua...Read more